Item 7.01 Regulation FD Disclosure.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1NGM Biopharmaceuticals, Inc. Corporate Presentation, datedJanuary 13, 2020 .
The information in this report, including the exhibit hereto, shall not be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that Section 11
and 12(a)(2) of the Securities Act of 1933, as amended. The information
contained herein and in the accompanying exhibit shall not be incorporated by
reference into any filing with the
--------------------------------------------------------------------------------
© Edgar Online, source